Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Income (Loss) (Unaudited)

v3.26.1
Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net sales $ 1,326.8 $ 1,259.1 $ 2,644.0 $ 2,480.8
Cost of sales [1] 296.3 276.9 587.4 542.1
Gross profit 1,030.5 982.2 2,056.6 1,938.7
Selling expenses [1] 466.0 445.9 927.8 879.3
General and administrative expenses 436.2 408.5 867.6 808.8
Other operating income 0.0 (4.8) (5.5) (4.8)
Operating income 128.3 132.6 266.7 255.4
Interest expense, net 37.4 53.6 84.2 105.6
Other expense, net 94.6 0.0 94.6 0.0
(Loss) Income before income taxes (3.7) 79.0 87.9 149.8
Income taxes 22.8 29.8 53.2 50.2
Net (loss) income (26.5) 49.2 34.7 99.6
Net loss attributable to noncontrolling interest (0.2) (0.1) (0.9) (0.1)
Net (loss) income attributable to Herbalife $ (26.3) $ 49.3 $ 35.6 $ 99.7
(Loss) Earnings per share attributable to Herbalife:        
Basic $ (0.25) $ 0.48 $ 0.34 $ 0.98
Diluted $ (0.25) $ 0.48 $ 0.33 $ 0.97
Weighted-average shares outstanding:        
Basic 104.5 102.7 104.0 102.2
Diluted 104.5 103.3 107.8 102.8
[1] The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.